AzTrials
AzTrials

Borderline Personality DisordersDBT+ContextNCT05972096

DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder

A study testing Combination DBT, self-compassion and contextual-based skills in people with Borderline Personality Disorders and BPD, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Although borderline personality disorder (BPD) tend to the clinical remission in long-term follow-up studies, a significant subgroup of patients continues to present long lasting symptoms such as low mood, emptiness and persistent impairment in psychosocial adjustment. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Borderline Personality Disorders, BPD
What is being tested?
Combination DBT, self-compassion and contextual-based skills
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteSpain
Study dates
1 Mar 2022to 1 Oct 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults between 18 and 65 years of age
  • Primary diagnosis of BPD according to Diagnostic Statistical Manual IV criteria and by the structured interviews: Diagnosis Structured clinical interview for axis II personality disorders (SCID II; First et al. 1997) and Diagnostic Interview for Borderlines Revised (DIB-R)
  • Previous participation in DBT-ST intervention
  • Signed informed consent.

Who cannot join

  • Presence of life-threatening behaviors in the last 12 months
  • PTSD or related symptoms
  • Diagnosis of drug-induced psychosis, organic brain syndrome, bipolar or psychotic disorder
  • Intellectual disability
  • Participation in any other psychotherapy treatment during the study.

Trial locations and contacts

1 site in 1 country.

Juan Carlos Pascual, PhD contact

34935537840

jpascual@santpau.cat

Spain1 site, 1 recruiting
  • Juan Carlos Pascual Mateos

    Barcelona, 08041

    Juan Carlos Pascual, PhD, +34935537840, jpascual@santpau.cat

    Recruiting

Other trials in Spain

About this study

Official title: Clinical Trial of Skills Training for Long Lasting Symptoms in Borderline Personality Disorder

Although borderline personality disorder (BPD) tend to the clinical remission in long-term follow-up studies, a significant subgroup of patients continues to present long lasting symptoms such as low mood, emptiness and persistent impairment in psychosocial adjustment. The prevalence of this subsample of individuals is considerably increasing last years. New interventions addressed to these individuals are need, the aim of this study is to evaluate the efficacy of a novel intervention combining dialectical behavioral therapy skills training with self-compassion and contextual-based skills for patients with long-lasting BPD.

Read the detailed description

Sixty individuals with BPD and long lasting symptoms that have been received previously dialectical-behavioral therapy skills training (DBT-ST) will be included in a randomized clinical trial. They will be randomly assigned to receive an add-on skills training intervention involving the combination of DBT-ST, self-compassion, and contextual-based skills for long lasting symptoms versus treatment as usual during 12-weeks. Patients will be evaluated pre and post intervention and 3-month follow-up. The outcome measures are well-being indicators and clinical variables.

Being tested
Combination DBT, self-compassion and contextual-based skills
Keywords
borderline personality disorder, long-lasting symptoms, dialectical behavior therapy skills, contextual approach.
Medical subject headings
Borderline Personality Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combination DBT, self-compassion and contextual-based skillsBehavioural

    Psychotherapy combination. Skills of DBT plus self-compassion and contextual skills

Study groups in NCT05972096
Study groupRoleWhat they receive
Combination of DBT-ST, self-compassion, and contextual-based skills.ExperimentalCombination of DBT-ST, self-compassion, and contextual-based skills.
Receives: Behavioral: Combination DBT, self-compassion and contextual-based skills
Control GroupPlacebo comparatorTreatment as usual. Although these individuals did not receive any new specific psychotherapeutic intervention for BPD, they valued the higher frequency of psychiatric visits, attention in crisis, family care, and greater experience and sensitivity in the management of BPD.
Receives: Behavioral: Combination DBT, self-compassion and contextual-based skills

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pemberton Happiness Index (PHI)

    Happiness index (minimum 0- maximum 110) Higher scores better

    Measured: 1 month

Secondary outcomes (6)
  1. Borderline Symptoms List-23 (BSL-23)

    Symptoms of Borderline (minimum 0- maximum 92). Higher scores worse

    Measured: 1 week

  2. Remission from Depression Questionnaire (RDQ)

    Depression (minimum 0- maximum 84). Higher scores worse

    Measured: 1 week

  3. Self Compassion Scale Short Form (SCS-SF)

    Compassion scale (12 items, minimum 12- maximum 60). Higher scores worse

    Measured: 1 month

  4. Forms of Self-Criticism/Self-Attacking and Self-Reassuring Scale (FSCRS)

    Self-criticism forms (14 items, minimum 0- maximum 56). Higher scores worse

    Measured: 1 month

  5. Satisfaction with life scale (SWLS)

    Well being (5 items, minimum 5 - maximum 25). Higher scores better

    Measured: 1 month

  6. Quality of life scale (WHO-QOL_BREF)

    Quality of life OMS (26 items, minimum 26- maximum 130). Higher scores better

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2023
  2. Study start1 Mar 2022
  3. Primary completion1 Oct 2023 (estimated)
  4. Study completion1 Oct 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized clinical trial aims to test the efficacy of this expanded skills DBT-based intervention with self-compassion and contextual-based skills targeting long-lasting BPD compared with treatment as usual.
Masking
Single blind
Who is masked
Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05972096
Sponsor's protocol ID
IIBSP-TLP-2020-104
Acronym
DBT+Context
Status last verified
Jul 2023
First submitted
17 Jul 2023
Last updated
2 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Combination DBT, self-compassion and contextual-based skills in people with Borderline Personality Disorders and BPD, run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Juan Carlos Pascual, PhD (34935537840, jpascual@santpau.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pemberton Happiness Index (PHI) (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in